Chembio Diagnostics, Inc.
CEMI · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -18.2% | 22.3% | -51.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 38.8% | 13.8% | 11.7% | 19.1% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 16.5% | -45.7% | -61.2% | -51.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -9.3% | -59.8% | -75.8% | -46.7% |
| EPS Diluted | -0.035 | -0.26 | -0.23 | -0.29 |
| % Growth | 86.5% | -13% | 20.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |